EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.7.10.1 | angiotensin II | - |
Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.10.1 | overexpression of VEGFR-1 tyrosine kinase in Tn5 cells | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.10.1 | 3-(N-3-carboxyphenylaminomethyl)-phenylboronic acid | inhibition of EGFR tyrosine kinase | Homo sapiens | |
2.7.10.1 | 4-(2',5'-dihydroxybenzylamino)phenylboronic acid | inhibition of EGFR tyrosine kinase | Homo sapiens | |
2.7.10.1 | 4-(N-3-carboxyphenylaminomethyl)-phenylboronic acid | inhibition of EGFR tyrosine kinase | Homo sapiens | |
2.7.10.1 | 4-methoxy-3-((2'-methoxybenzylamino)methyl)phenylboronic acid | inhibition of EGFR tyrosine kinase | Homo sapiens | |
2.7.10.1 | 5-(4-(dihydroxyboranyl)benzylamino)-2-hydroxybenzoic acid | inhibition of EGFR tyrosine kinase | Homo sapiens | |
2.7.10.1 | active pharmacophore 1 | derivative of lavendustin A, inhibition of EGFR tyrosine kinase | Homo sapiens | |
2.7.10.1 | additional information | inhibitory potency of diverse aminoboronic acids, e.g. no inhibition of EGFR tyrosine kinase by 3-(2,5-dihydroxybenzylamino)phenylboronic acid, overview | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.7.10.1 | membrane | EGFR tyrosine kinase | Homo sapiens | 16020 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.10.1 | Mg2+ | - |
Homo sapiens | |
2.7.10.1 | Mn2+ | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.10.1 | ATP + [endothelial growth-factor]-L-tyrosine | Homo sapiens | EGFR tyrosine kinase | ADP + [endothelial growth-factor]-L-tyrosine phosphate | - |
? | |
2.7.10.1 | ATP + [vascular endothelial growth-factor-1]-L-tyrosine | Homo sapiens | VEGFR-1 tyrosine kinase | ADP + [vascular endothelial growth-factor-1]-L-tyrosine phosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.10.1 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.10.1 | A-431 cell | EGFR tyrosine kinase | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.10.1 | ATP + [endothelial growth-factor]-L-tyrosine | EGFR tyrosine kinase | Homo sapiens | ADP + [endothelial growth-factor]-L-tyrosine phosphate | - |
? | |
2.7.10.1 | ATP + [vascular endothelial growth-factor-1]-L-tyrosine | VEGFR-1 tyrosine kinase | Homo sapiens | ADP + [vascular endothelial growth-factor-1]-L-tyrosine phosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.10.1 | EGFR tyrosine kinase | - |
Homo sapiens |
2.7.10.1 | epidermal growth-factor receptor tyrosine kinase | - |
Homo sapiens |
2.7.10.1 | vascular endothelial growth-factor receptor-1 tyrosine kinase | - |
Homo sapiens |
2.7.10.1 | VEGFR-1 tyrosine kinase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.7.10.1 | 25 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.7.10.1 | 7.4 | - |
assay at | Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.7.10.1 | ATP | - |
Homo sapiens |